Article
Bioinformatics and immunoinformatics to support COVID‐19 vaccine development
15 Apr 2021
Abstract excerpt
Severe acute respiratory syndrome coronavirus 2 has infected over 109 000 000 people with 2 423 443 deaths as of February 17, 2021. Currently, there are no approved or consistently effective treatments, and conventional vaccines may take several years for development and testing. In silico methods of bioinformatics, vaccinogenomics, immunoinformatics, structural biology, and molecular simulations can be used for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
